🔗 Permalink

Inventor profile of:

Hermona Soreq

City:

Jerusalem

Country:

Israel

Published Applications:

33

Last publication date:

2022-03-31

Top Assignees for applications by Hermona Soreq

The entities that hold a legal rights for patent applications filed by inventor Soreq Hermona:

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM 13 Jerusalem, Israel
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. 10 Jerusalem, Israel
Medical Research Fund at the Tel Aviv Sourasky Medical Center 2 Tel Aviv, Israel
PROTALIX LTD. 1 Carmiel, Israel
Ben-Gurion University of Negev, Research & Development Authority 1 Beersheva, Israel
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW 1 Jerusalem, Israel
MOR RESEARCH APPLICATIONS LTD. 1 Petach Tikva, Israel
Uriah Bekenstein 1 Rehovot, Israel

Recent patent applications by Soreq Hermona

Hermona Soreq from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-03-31

US20220098588A1

Chemistry; metallurgy

METHODS FOR CONTROLLING SEIZURES BY MANIPULATING THE LEVELS OF MICRORNA-211 (miR-211) IN THE BRAIN

#2 | 2020-04-02

US20200102559A1

Chemistry; metallurgy

Methods for controlling seizures by manipulating the levels of microRNA-211 (miR-211) in the brain

#3 | 2019-12-26

US20190390077A1

Chemistry; metallurgy

Hybrid nanoparticles as photoinitiators

#4 | 2019-03-14

US20190078090A1

Chemistry; metallurgy

DOWNREGULATING MIR-132 FOR THE TREATMENT OF LIPID RELATED DISORDERS

#5 | 2018-12-13

US20180355200A1

Chemistry; metallurgy

Hybrid nanoparticles as photoinitiators

#6 | 2017-10-05

US20170283800A1

Chemistry; metallurgy

Downregulating miR-132 for the treatment of lipid related disorders

#7 | 2015-04-30

US20150119447A1

Chemistry; metallurgy

CLUSTERED SINGLE NUCLEOTIDE POLYMORPHISMS IN THE HUMAN ACETYLCHOLINESTERASE GENE AND USES THEREOF IN DIAGNOSIS AND THERAPY

#8 | 2013-11-28

US20130317092A1

Human necessities

AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL

#9 | 2013-11-21

US20130310441A1

Human necessities

Antisense oligonucleotides against AChE in the treatment of gastrointestinal inflammation disorders

#10 | 2013-08-15

US20130210901A1

Chemistry; metallurgy

METHOD OF TREATING NEURODEGENERATIVE DISEASES

#11 | 2013-06-27

US20130164288A1

Chemistry; metallurgy

READTHROUGH ACETYLCHOLINESTERASE (ACHE-R) FOR TREATING OR PREVENTING PARKINSON'S DISEASE

#12 | 2013-01-17

US20130018081A1

Human necessities

AChE ANTISENSE OLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT

#13 | 2012-11-22

US20120295963A1

Human necessities

AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL

#14 | 2011-06-09

US20110136897A1

Chemistry; metallurgy

TOLL-LIKE RECEPTOR 9 AGONISTS FOR THE TREATMENT OF ANXIETY-RELATED DISORDERS AND INFLAMMATORY DISORDERS

#15 | 2011-03-17

US20110064716A1

Human necessities

MATERIALS AND METHODS FOR TREATING OR PREVENTING ORGANOPHOSPHATE EXPOSURE ASSOCIATED DAMAGE

#16 | 2011-02-17

US20110039791A1

Human necessities

ACETYLCHOLINESTERASE (ACHE)-DERIVED PEPTIDE AS AN INDUCER OF GRANULOCYTOPOIESIS, USES AND METHODS THEREOF

#17 | 2010-11-04

US20100279381A1

Chemistry; metallurgy

Acetylcholinesterase (AChE) variants of the N-terminus

#18 | 2010-08-26

US20100216868A1

Human necessities

AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL

#19 | 2009-11-12

US20090281165A1

Chemistry; metallurgy

Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof

#20 | 2009-07-02

US20090169520A1

Chemistry; metallurgy

Compounds, Pharmaceutical Compositions and Therapeutic Methods of Preventing and Treating Diseases and Disorders Associated With Amyloid Fibril Formation

#21 | 2008-12-11

US20080306014A1

Chemistry; metallurgy

Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial

#22 | 2007-12-20

US20070293452A1

Chemistry; metallurgy

Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial

#23 | 2007-09-27

US20070224181A1

Human necessities

Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof

#24 | 2007-03-22

US20070065882A1

Chemistry; metallurgy

Acetylcholinesterase-derived peptides and uses thereof

#25 | 2007-02-15

US20070037241A1

Chemistry; metallurgy

Method for assessing trait anxiety by determining cholinergic status

#26 | 2006-08-10

US20060178333A1

Chemistry; metallurgy

Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof

#27 | 2006-07-27

US20060166204A1

Chemistry; metallurgy

Parkinson's disease susceptibility haptotype as a tool for genetic screening

#28 | 2006-07-11

US10402016

Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof

#29 | 2006-06-27

US9998042

Acetylcholinesterase-derived peptides and uses thereof

#30 | 2006-06-20

US9980263

Uses of antibodies against AChE and peptides thereof

#31 | 2006-06-08

US20060121536A1

Chemistry; metallurgy

Novel uses of antibodies against AChE and peptides thereof

#32 | 2006-03-30

US20060069051A1

Human necessities

AChE antisense oligonucleotide as an anti-inflammatory agent

#33 | 2006-01-17

US9310638

Transgenic non-human mammals producing a cholinesterase in their milk

InventorID:

42619 ⎘